Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Efficacy and Safety of Mometasone Furoate Aqueous Nasal Spray vs Placebo and Flonase® (Fluticasone Propionate) in Seasonal Allergic Rhinitis Patients (I94-001)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03882047
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:48.489425+00:00
Published At
2019-09-06T00:00:00+00:00
Record Updated At
2022-02-09
Results Posted At
2019-09-06
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Rhinitis, Allergic, Seasonal"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2022-02-09"
protocolSection.identificationModule.nctId
"NCT03882047"
protocolSection.identificationModule.officialTitle
"Efficacy and Safety of Mometasone Furoate Aqueous Nasal Spray vs Placebo and Flonase\u00ae (Fluticasone Propionate) in Seasonal Allergic Rhinitis Patients (I94-001)"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2019-09-06"

Study condition terms

  • Rhinitis, Allergic, Seasonal (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.